We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$10.2B
AUM Growth
+$2.04B
(+25%)
Cap. Flow
+$1.34B
Cap. Flow
% of AUM
13.16%
Top 10 Holdings %
Top 10 Hldgs %
16.92%
Holding
1,109
New
201
Increased
523
Reduced
236
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$57.2M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$52.3M |
| 3 |
Micron Technology
MU
|
+$46M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$45.6M |
| 5 |
Apple
AAPL
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$76.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$62.9M |
| 3 |
NVR
NVR
|
+$49.7M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$37.5M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$35.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 15.64% |
| 3 | Healthcare | 14.3% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Lockheed Martin
LMT
$134B
| $438K | ﹤0.01% |
1,124
-38,708
| -97% | -$14.9M |
|
|
AVYA
802
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
| $437K | ﹤0.01% |
+32,350
| New | +$397K |
|
|
ALEX
803
DELISTED
Alexander & Baldwin
ALEX
| $433K | ﹤0.01% |
20,638
+5,245
| +34% | +$119K |
|
|
WIRE
804
DELISTED
Encore Wire Corp
WIRE
| $428K | ﹤0.01% |
7,458
-1,593
| -18% | -$91.4K |
|
805
Marker Therapeutics
MRKR
$20.3M
| $427K | ﹤0.01% |
+14,828
| New | +$539K |
|
|
CBAY
806
DELISTED
Cymabay Therapeutics
CBAY
| $425K | ﹤0.01% |
216,609
+166,759
| +335% | +$626K |
|
807
Carter Bankshares
CARE
$756M
| $421K | ﹤0.01% |
+17,762
| New | +$367K |
|
808
Procter & Gamble
PG
$343B
| $419K | ﹤0.01% |
3,355
-1,675
| -33% | -$205K |
|
809
Corvus Pharmaceuticals
CRVS
$1.1B
| $413K | ﹤0.01% |
75,996
+32,979
| +77% | +$115K |
|
810
Mitek Systems
MITK
$762M
| $406K | ﹤0.01% |
+53,018
| New | +$447K |
|
811
Home Bancorp
HBCP
$552M
| $404K | ﹤0.01% |
10,313
+2,197
| +27% | +$85.3K |
|
|
GMS
812
DELISTED
GMS Inc
GMS
| $398K | ﹤0.01% |
+14,713
| New | +$432K |
|
|
USX
813
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $396K | ﹤0.01% |
+78,819
| New | +$384K |
|
814
MACOM Technology Solutions
MTSI
$20.4B
| $395K | ﹤0.01% |
14,861
+1,661
| +13% | +$39.7K |
|
|
SAGE
815
DELISTED
Sage Therapeutics
SAGE
| $394K | ﹤0.01% |
+5,454
| New | +$671K |
|
|
CSTR
816
DELISTED
CapStar Financial Holdings, Inc
CSTR
| $394K | ﹤0.01% |
+23,682
| New | +$396K |
|
|
DRNA
817
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $393K | ﹤0.01% |
17,829
-14,100
| -44% | -$284K |
|
|
ELGX
818
DELISTED
Endologix Inc
ELGX
| $390K | ﹤0.01% |
246,936
+124,894
| +102% | +$349K |
|
819
Assembly Biosciences
ASMB
$506M
| $383K | ﹤0.01% |
1,562
+448
| +40% | +$82.5K |
|
|
SNV
820
DELISTED
Synovus
SNV
| $380K | ﹤0.01% |
+9,700
| New | +$356K |
|
|
TACO
821
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $376K | ﹤0.01% |
+47,554
| New | +$385K |
|
822
The Joint Corp
JYNT
$119M
| $374K | ﹤0.01% |
23,150
-200
| -0.9% | -$3.64K |
|
823
ServiceNow
NOW
$102B
| $373K | ﹤0.01% |
6,610
-183,895
| -97% | -$9.69M |
|
|
PKD
824
DELISTED
Parker Drilling Company
PKD
| $372K | ﹤0.01% |
+16,528
| New | +$319K |
|
825
Southwest Airlines
LUV
$22.1B
| $367K | ﹤0.01% |
6,794
+1,594
| +31% | +$88.4K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2019 Portfolio in Review
As of Q4 2019, Jacobs Levy Equity Management held 1,109 positions worth $10.2B, up 25% from $8.15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.34B of net new capital in Q4 2019, opening 201 new positions and adding to 523 existing holdings. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Qualcomm, an estimated $76.7M trimmed.
- Jacobs Levy Equity Management's largest Q4 2019 buy was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
- Jacobs Levy Equity Management added most to AbbVie in Q4 2019, an estimated $57.2M increase.
- Jacobs Levy Equity Management's biggest Q4 2019 reduction was Qualcomm, cutting an estimated $76.7M.
- Jacobs Levy Equity Management fully exited NVR in Q4 2019, selling an estimated $49.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $10.2B portfolio in Q4 2019.
- Jacobs Levy Equity Management opened 201 new positions and closed 122 in Q4 2019.
- Jacobs Levy Equity Management's portfolio value rose 25% quarter-over-quarter to $10.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.